Teleflex to Present at First European Emergency Medical Service Congress (“EMS2016”) in Copenhagen
May 26 2016 - 6:45AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care, urology and surgery, is
committed to connecting clinicians with technology in a way that
improves clinical practice and advances patient outcomes. Teleflex
will showcase its Arrow® EZ-IO® Intraosseous Vascular Access System
and other products for rescue airway, atomization and intubation
needs at the first European Emergency Medical Service Congress
(“EMS 2016”) to be held in Copenhagen, Denmark, on May 30-June 1,
2016.
Achieving better treatment for the patient is the goal of this
event, which will highlight the latest knowledge on best practices
and the newest equipment in the area of emergency medical services
and pre-hospital care.
This is a perfect setting for Teleflex to focus on its Arrow®
EZ-IO® Intraosseous Vascular Access System.
The Arrow® EZ-IO® Intraosseous Vascular Access System from
Teleflex is an innovative and complete solution for rapid vascular
access – whether the emergency responder is facing difficult
vascular access challenges or the need for fast intraosseous access
for critical situations and life-threatening emergencies. This
system is designed to provide the medical professional vascular
access to the central circulation system within seconds1,
delivering medications, intravenous fluids and blood products to
adult and pediatric patients alike.
The Teleflex Clinical & Medical Affairs team will be at the
booth to conduct resuscitation scenarios on high fidelity
simulation models. The team of highly experienced clinicians will
demonstrate the latest evidence based interventions related to
intraosseous needle placement. These interactive sessions will help
educate clinicians from around Europe, improving patient outcomes
through advancing clinical practice.
Teleflex will also feature the LMA® Supreme™ Airway and the LMA®
MAD Nasal™ Intranasal Mucosal Atomization Device.
The LMA® Supreme™ Airway is the market leading second generation
subglottic airway. The gastric drain tube channels secretions away
from the airway in compliance with NAP4 guidelines. Effective first
and second seal technology truly separates the digestive tract from
the airway making this the first choice subglottic airway for
emergency use.
When IV drug delivery is less than ideal, the LMA® MAD Nasal™
Device2 from Teleflex can come to the rescue, delivering safe,
painless and rapidly effective treatment. No needle. No trauma. No
risk of needle stick injury.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, EZ-IO, Hudson RCI,
LMA, LMA Supreme, MAD Nasal, Pilling, and Weck are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates,
in the U.S. and/or other countries. © 2016 Teleflex Incorporated.
All rights reserved.
References:
1. Von Hoff DD , Kuhn JG, Burris HA, Miller LJ. Does
intraosseous equal intravenous? A pharmacokinetic study. Amer J
Emerg Med 2008;26:31-8
2. For use with drugs approved for intranasal delivery
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160526005094/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836orMartina Teichmann-ZindlerDirector
Marketing Communications International+49
(0)7151-406-538martina.teichmann@teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2024 to May 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From May 2023 to May 2024